TP53 and cancer: Among the ongoing attempts to discover MDM4 inhibitors, ALRN-6924, an α-helical stapled peptide, that acts as dual MDM2/MDM4 inhibitor demonstrated high efficacy against multiple cancer cell lines possessing wt p53 (Figure 7B) [152].